Health-Related Quality of Life Coupled With Therapeutic Information on Compliance to Endocrine Therapy in Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

342

Participants

Timeline

Start Date

May 14, 2021

Primary Completion Date

April 30, 2025

Study Completion Date

October 31, 2025

Conditions
Breast Cancer
Interventions
OTHER

Routine Assessment of HRQoL coupled with Therapeutic Information

Participants will complete the EORTC-QLQ-C30 and EORTC-QLQ-BR23 questionnaires before their consultation via the CHES software. The scores will then be generated and provided to clinicians in a graphic form, describing scores course. Access to CHES web portal will also be open to participants outside consultation time points, to enable them to monitor HRQoL if necessary. Workshop 1, will help patients to recognize and react to the occurrence of possible adverse effects, and anticipate their occurrence through appropriate preventive means. In workshop 2, participants will have the opportunity to express their representations and experiences related to their diet and the consequences of disease and treatments on diet. In workshop 3, participants can describe their experiences of fatigue and how their life is affected by it. Moreover, they can identify possible causes and finally discuss solutions to better this symptom. Every month, a reminder letter will also be sent to participants.

Trial Locations (1)

Unknown

RECRUITING

Centre Georges François Leclerc, Dijon

All Listed Sponsors
lead

Centre Georges Francois Leclerc

OTHER

NCT04176809 - Health-Related Quality of Life Coupled With Therapeutic Information on Compliance to Endocrine Therapy in Breast Cancer | Biotech Hunter | Biotech Hunter